A meeting to turbo-charge the Active Pharmaceuticals Ingredients or API Industry was organized in NITI Aayog under the chairmanship of CEO Amitabh Kant. The Department of Pharmaceuticals (DOP) made a detailed presentation on the history and status of the API industry and the challenges faced by it and the various options available to make India a powerhouse in Key Starting Materials, Intermediates and Active Pharmaceuticals Ingredients (API).
DoP shared its vision and recent efforts in promoting bulk drug parks in the country. Issues related to environmental clearances were discussed in detail and industry was promised fast approvals. Principal Secretary (Industry), Government of Telangana, explained various incentives offered by the Government of Telangana and invited the industry to set up manufacturing units in Hyderabad Pharma City.
Leaders of the pharma industry shared their perspective on the situation and suggested various measures to be taken by the government. Amitabh Kant exhorted the industry to become internationally competitive and go for a global scale of operations. He assured that Government of India will take all necessary steps to support the industry in its endeavours.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
